| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-07 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.15 | 6e-06 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-05 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-05 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.15 | 0.001 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.35 | 0.003 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.14 | 0.004 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.094 | 0.005 |